Valion Bio, Inc. (VBIO) stock
VBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.53+0.02 (+4.05%)
Close on Nov 13, 2026Market cap $2.20MP/E –Yield –
Valion Bio operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Valion Bio's operating cash flow for the twelve months ending Jun 30, 2026 was -$14.58M. For fiscal 2025 it was -$7.00M. The highest annual figure on record is -$5.61M in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$7.00M | – |
| FY2024 | Dec 31, 2024 | -$5.73M | – |
| FY2023 | Dec 31, 2023 | -$8.51M | – |
| FY2022 | Dec 31, 2022 | -$8.92M | – |
| FY2021 | Dec 31, 2021 | -$5.61M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$5.28M | – |
| Q1 FY2026 | Mar 31, 2026 | -$5.01M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.29M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.00M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.83M | – |
| Q1 FY2025 | Mar 31, 2025 | -$889.00K | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.37M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.41M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.29M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.67M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.77M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.87M | – |
| Q2 FY2023 | Jun 30, 2023 | -$2.44M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.43M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.23M | – |
| Q3 FY2022 | Sep 30, 2022 | -$2.77M | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.75M | – |
| Q1 FY2022 | Mar 31, 2022 | -$2.17M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.76M | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.64M | – |
| Q2 FY2021 | Jun 30, 2021 | -$543.00K | – |
| Q1 FY2021 | Mar 31, 2021 | -$665.00K | – |
See a number that looks wrong?